semaglutide drug mounjaro What's better for weight loss, or Ozempic? New study provides answer Thinking of Taking Mounjaro or

Cardiometabolic Improvements Weight loss was accompanied by clinically meaningful improvements across several cardiovascular risk markers, including reductions in: Waist circumference (mean reduction of approximately 24.1 cm at the highest dose) Non-HDL cholesterol Triglycerides Systolic blood pressure High-sensitivity C-reactive protein (hsCRP) a marker of inflammation These findings are particularly relevant for patients with obesity who also live with cardiometabolic conditions, where systemic risk reduction is as important as the weight loss itself

View details Recovery & Structural BPC/TB5 Blend The BPC-157 + TB-500 blend combines two of the most researched structural and recovery peptides into a single research formulation, studied across structural, vascular, and epithelial models

July 2, 2025: Mounjaro Patients in the United Kingdom Are Reporting Severe Pancreas Issues Mounjaro patients are experiencing severe pancreatitis (inflammation of the pancreas) and have had to be hospitalized

And ultimately, the patients are the ones who suffer

This gives both of you objective information rather than relying on memory

Starting at $129/month allows you to assess tolerance while your prescriber monitors your response and adjusts your dose as needed at no additional cost